Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
Recruiting · NCT07520006 · Registry updated 2026-08-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies | B-cell chronic lymphocytic leukemia, B-cell neoplasm, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-08-28 | NCT07520006 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nurix Therapeutics, Inc. | 6 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Oncology Associates of Oregon | Eugene | United States | 12 |
| Rocky Mountain Cancer Centers | Aurora | United States | 15 |
| Scri Oncology Partners | Nashville | United States | 156 |
| Texas Oncology - Northeast | Tyler | United States | 6 |
| University of Miami | Coral Gables | United States | 34 |
| UPMC Hillman Cancer Center | Pittsburgh | United States | 330 |